CONMED Corporation (CNMD) stock slides, “Buy” rating reaffirmed by Needham & Company LLC Analysts

CONMED Corporation (NASDAQ: CNMD) shares fell on Thursday February 2 on heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, The Dow Jones Industrial Average DJIA, -0.10% fell 34 points, or 0.2%, to 19,858. The S&P 500 SPX, -0.11% lost 4 points to 2,276, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.05% slid 16 points, or 0.3%, to 5,626. Among the most actively traded Nasdaq stocks was Facebook Inc FB, +0.31% which fell 0.7% a day after it reported its quarterly results.

Analysts at Needham & Company LLC reiterated a Buy rating on shares of CONMED Corporation (NASDAQ: CNMD) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. With a rating of Buy on the stock, the company has a 52-week high of $50.16. As a means of comparison, a number of other analysts have commented on the company in recent days, and CONMED Corporation has secured a consensus one-year price target of $48.75, higher than the opening price of $41.97, a difference of 11.61 percent. Share prices sometimes get a bounce to the upside when analysts reiterate coverage.

Yesterday CONMED Corporation (NASDAQ: CNMD) shares last traded at $42.00, a drop of $2.27 over the previous closing price. Opening at $41.97, they fluctuated from $40.21 and $42.19 throughout the day.

CONMED Corporation (NASDAQ: CNMD) currently has a market cap of 1.17B.

CONMED Corporation (NASDAQ: CNMD) Average Daily Trading Volume

212,229 shares crossed the trading desk yesterday, 61 percent higher than the average, out of a total float 24,731,000. higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain teams of analysts that investigate thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

CONMED Corporation (NASDAQ: CNMD) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, CONMED Corporation (NASDAQ: CNMD) now has a 50-day MA of $44.21 and 200-day MA of $42.27. It has traded in a 52-week range between $35.51 – 50.16 and today’s last price is 16.27%% lower than the 52 week high of $50.16.

Earnings growth is a critical factor to look at when investing in stocks and investors identify companies that have raised their earnings by at least 25% over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply